SCHEMBL1927508

SCHEMBL1927508

CC(C)CCNC(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 1.00
RAB9A P51151 2/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
DRD2 P14416 2/20 0.58
DRD4 P21917 2/20 0.58
DRD3 P35462 2/20 0.58
EPHX2 P34913 1/20 0.57
KCNA5 P22460 1/20 0.56
HIF1A Q16665 1/20 0.56
NAMPT P43490 1/20 0.55
TRPV1 Q8NER1 1/20 0.55
GRM5 P41594 1/20 0.55
POLB P06746 2/20 0.55
TP53 P04637 1/20 0.55
LMNA P02545 2/20 0.54
HDAC3 O15379 1/20 0.54
HDAC4 P56524 1/20 0.54
HDAC1 Q13547 1/20 0.54
HDAC7 Q8WUI4 1/20 0.54
HDAC2 Q92769 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL496789 0.90 SMN1; SMN2 (0.81) NPC1RAB9ASMN1; SMN2EPHX2KCNA5
SCHEMBL17887994 0.88 SMN1; SMN2 (0.77) NPC1RAB9ASMN1; SMN2EPHX2KCNA5
SCHEMBL17225741 0.87 SMN1; SMN2 (0.77) NPC1RAB9ASMN1; SMN2EPHX2KCNA5
SCHEMBL1927498 0.86 SMN1; SMN2 (0.76) NPC1RAB9ASMN1; SMN2EPHX2KCNA5
SCHEMBL5869095 0.83 NPC1 (0.71) NPC1RAB9ASMN1; SMN2DRD2DRD4
SCHEMBL5943961 0.83 SMN1; SMN2 (0.71) NPC1RAB9ASMN1; SMN2NAMPTLMNA
SCHEMBL5869102 0.83 NPC1 (0.71) NPC1RAB9ASMN1; SMN2DRD2DRD4
SCHEMBL5869108 0.83 NPC1 (0.71) NPC1RAB9ASMN1; SMN2DRD2DRD4
SCHEMBL18082335 0.83 NPC1 (0.71) NPC1RAB9ASMN1; SMN2DRD2DRD4
SCHEMBL3638357 0.83 GRM5 (0.73) NPC1RAB9ASMN1; SMN2EPHX2KCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763509-B1 ALPHA-HELICAL MIMETICS WALTER & ELIZA HALL INST MEDICAL RES (AU) 2018-02-21 EP disclosed
US-7956216-B2 Benzoyl urea derivatives mimicing BH3-only proteins, able to interact with a Bcl-2 protein THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2011-06-07 US disclosed
US-20090042855-A1 BENZAMIDE mGluR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME DEPARTMENT OF VETERANS AFFAIRS 2009-02-12 US disclosed
WO-2008151184-A1 BENZAMIDE MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME VANDERBILT UNIVERSITY (US) 2008-12-11 WO disclosed
US-20080153802-A1 Alpha-helical mimetics THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2008-06-26 US disclosed
EP-1763509-A1 ALPHA-HELICAL MIMETICS THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2007-03-21 EP disclosed
WO-2006002474-A1 ALPHA-HELICAL MIMETICS THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042855-A1 BENZAMIDE mGluR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME GRM5, GRIK5, GRM3 NPC1 2371/4885RAB9A 3119/4885SMN1; SMN2 2385/4885
US-20080153802-A1 Alpha-helical mimetics BID, BAX, BAD NPC1 3792/4885RAB9A 2719/4885SMN1; SMN2 860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.